Central New England’s Highest Positive Rates

According to Quest Diagnostics, 2016 saw continued changes in drug test positive rates in Central New England. In Massachusetts, Plymouth, Cape Cod, Framingham, Worcester and Springfield have the highest overall laboratory positive rates in the state (5.5% or greater). In Connecticut, New London County had the highest overall positive rate for the state (5.5% or greater).
Not surprisingly, marijuana positives were the most frequent laboratory positive in both Massachusetts (2.7%) and Connecticut (2.0%).
The next highest laboratory positive rate in both states was for amphetamines (1.3%), but this number is likely contributed to by prescriptions for medications from that category (see drugs used to treat ADHD).
These data are laboratory positives and do not reflect MRO-confirmed positive rates, nor do they include synthetic opioid positive rates. The overall positive rate nationally as analyzed by Quest Diagnostics is over 4%. Though this rate reflects raw laboratory data, it is still relevant to the overall positive rate confirmed by MROs, and may have significant impact on the industry.
Smart Test provides drug testing in Boston, MA. For more information, visit smarttestboston.com
Location: 240 Commercial St., FL 3, Boston, MA 02109, United States

Comments

Post a Comment

Popular posts from this blog

Patrice Kelly named Director of ODAPC

Patrice Kelly, former Acting Director of the Drug of Alcohol Policy and Compliance (ODAPC) has been named Director of ODAPC . Her directorship comes at the best-possible time for public safety, as the USDOT plans to allow for the testing of an expanded opioid panel in the current five panel tests currently mandated. Under her role as Acting Director, ODAPC increased public outreach, fostered safety program improvements in industry, and was central in guiding all DOT modes through the changing state laws regarding cannabis and the opioid crisis. The industry can expect Director Kelly and her team at ODAPC to continue to provide guidance and clarification to transportation safety in a rapidly changing landscape, and to lead a safety program which directly impacts the US roads, skies, waterways, and pipelines. Smart Test 240 Commercial St. Boston MA 02109
Read more

DNA Testing In Boston

Image
The rise of affordability on DNA testing has allowed for substantial increases in its applicability.  From DNA testing for US Immigration to testing for ancestry research and maternity/paternity cases, the biggest obstacles to testing are the cost of the test, the reliability and defensibility of the results, and the timeframe to receive results. Following testing protocols without error at the time of collection are required for a specimen to be valid and defensible, and a laboratory which can provide fast-yet-accurate results. Popular DNA testing services for ancestry can take up to eight weeks and paternity tests can take several weeks. Smart Test provides affordable testing with legally valid results in under a week. DNA testing in Boston is now faster, more accurate, secure and confidential at an affordable price. Smart Test Boston (617) 963–8378 240 Commercial St. Boston, MA 02109
Read more

Oral Fluids Testing — Current Barriers to USDOT Approval

Image
Oral Fluids Testing — Current Barriers to USDOT Approval Oral fluids testing offered by several national drug testing labs ( Quest , Alere , and Omega for example) provides a new method for the detection of metabolites for drug testing, but is not currently approved for use by the USDOT. One barrier that currently exists is that the USDOT requires the ability to split each specimen. Two oral fluid testing devices would be considered two separate specimens in the eyes of the DOT, and therefor unacceptable. One clear solution is for the collection swab to be split into two pieces and be deposited into two vials, just like a urine specimen. For this to work, it must be built into the device, as manually cutting the swab would risk contamination. Another problem faced by the labs is in the collection process itself. The current methods mostly involve the employee (or “donor”) handling the specimen collection device and to place the swab into the vials, with the collector...
Read more